Brien Ragle - IsoRay CFO

ISRDelisted Stock  USD 0.38  0.01  2.70%   

CFO

Mr. Brien Ragle is Chief Financial Officer of IsoRay Inc. Mr. Ragle has over 15 years of finance and accounting experience including SEC reporting financial reporting cost project and management accounting in addition to performing operational analysis. Mr. Ragle became IsoRay Chief Financial Officer on October 1 2013. Mr. Ragle was IsoRay Controller Principal Financial and Accounting Officer from October 2009 to September 2013. Mr. Ragle was IsoRays Cost Accounting Manager from January 2007 until October 2009. Before joining IsoRay in January 2007 as Cost Accounting Manager Mr. Ragle was employed by BNG America LLC a whollyowned subsidiary of Energy Solutions LLC from 2005 to 2006 as Project Accounting Manager for all projects located in the Western United States and from 2000 to 2004 as a Business Unit Controller by SCM Consultants Inc a whollyowned subsidiary of Tetra Tech Inc . Mr. Ragle holds Bachelor of Arts degrees in Business Administration with an emphasis in accounting and in Hospitality Management from Washington State University. Mr. Ragle is a Certified Public Accountant in the State of Washington and designated as a Chartered Global Management Accountant by the American Institute of Certified Public Accountants since 2013.
Age 45
Tenure 11 years
Phone509 375 1202
Webhttps://isoray.com
Ragle filed for personal bankruptcy under Chapter 13 of the U.S. Bankruptcy Code on January 26, 2011.

IsoRay Management Efficiency

The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 10 records

CFO Age

Sudhanshu PriyadarshiKeurig Dr Pepper
46
Richard GowardWillamette Valley Vineyards
59
Ran VeredRadcom
N/A
Brian HarrissTurning Point Brands
63
Brad WolfeAsure Software
54
Uri BirenbergRadcom
38
Kelyn BrannonAsure Software
58
Amir HaiRadcom
51
Andrew FlynnTurning Point Brands
48
Kathy WallerThe Coca Cola
58
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people. IsoRay Inc (ISR) is traded on NYSE MKT Exchange in USA and employs 66 people.

Management Performance

IsoRay Inc Leadership Team

Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller
Alan Hoffmann, Independent Director
Lisa Lauer, Vice President - Business Development
Lori Woods, Interim Chief Executive Officer, Director
Michael McCormick, Independent Chairman of the Board
Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer
Thomas LaVoy, Independent Director
William Cavanagh, Vice President - Research and Development
Lori HolmesWoods, CEO Director
Michael Krachon, Vice President, Director of Sales and Marketing
Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources
Mark CPA, Controller, Fin
William III, Chief Officer
Philip Vitale, Independent Director
Krista Cline, Senior Director of Operations, Corporate Secretary
Matthew Branson, Principal Financial Officer
Patricia Mills, NE Area Sales Director
Brien Ragle, CFO

IsoRay Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IsoRay in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IsoRay's short interest history, or implied volatility extrapolated from IsoRay options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in IsoRay Stock

If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world